OATH SCIENCES Trademark
Trademark Overview
On Wednesday, October 22, 2025, a trademark application was filed for OATH SCIENCES with the United States Patent and Trademark Office. The USPTO has given the OATH SCIENCES trademark a serial number of 99457455. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, October 22, 2025. This trademark is owned by Caper Labs, Inc.. The OATH SCIENCES trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for alleviating side effects of cancer treatments; Pharmaceutical preparations for alleviating side effects of chemotherapy; Pharmaceutical preparations for alleviating side effects of radiation therapy; Pharmaceutical preparations for alleviating side effects of targeted cancer
treatments; Pharmaceutical preparations for alleviating side effects of
targeted cancer treatments, namely, tyrosine kinase inhibitors; Pharmaceutical preparations for alleviating side effects of immunotherapy
treatments; Pharmaceutical preparations for alleviating gastrointestinal
distress, mucocitis, nausea, vomiting and diarrhea; Pharmaceutical preparations for stimulating appetite; Pharmaceutical preparations for preventing weight loss; Pharmaceutical preparations for protecting bone
marrow and the production of bone marrow; Pharmaceutical preparations for protecting stem cells and stimulating the production of stem cell...
General Information
| Serial Number | 99457455 |
| Word Mark | OATH SCIENCES |
| Filing Date | Wednesday, October 22, 2025 |
| Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
| Status Date | Wednesday, October 22, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for alleviating side effects of cancer treatments; Pharmaceutical preparations for alleviating side effects of chemotherapy; Pharmaceutical preparations for alleviating side effects of radiation therapy; Pharmaceutical preparations for alleviating side effects of targeted cancer
treatments; Pharmaceutical preparations for alleviating side effects of
targeted cancer treatments, namely, tyrosine kinase inhibitors; Pharmaceutical preparations for alleviating side effects of immunotherapy
treatments; Pharmaceutical preparations for alleviating gastrointestinal
distress, mucocitis, nausea, vomiting and diarrhea; Pharmaceutical preparations for stimulating appetite; Pharmaceutical preparations for preventing weight loss; Pharmaceutical preparations for protecting bone
marrow and the production of bone marrow; Pharmaceutical preparations for protecting stem cells and stimulating the production of stem cells; Pharmaceutical preparations for increasing resiliency of stem cells,
increasing the number of stem cells, and preventing the reduction of stem
cell populations; Pharmaceutical preparations for protecting blood cells,
alleviating anemia, neutropenia, thrombocytopenia, and alleviating low
blood counts; Pharmaceutical preparations for alleviating dose limiting side
effects of cancer treatments, chemotherapy, radiation therapy, targeted
cancer treatments and immunotherapy treatments; Pharmaceutical preparations for the prevention and treatment of side effects of cancer
treatments; Pharmaceutical preparations for the prevention and treatment of
side effects of chemotherapy; Pharmaceutical preparations for the prevention
and treatment of side effects of radiation therapy; Pharmaceutical preparations for the prevention and treatment of side effects of targeted
cancer treatments; Pharmaceutical preparations for the prevention and
treatment of side effects of targeted cancer treatments, namely, tyrosine
kinase inhibitors; Pharmaceutical preparations for the prevention and
treatment of side effects of immunotherapy treatments; Pharmaceutical preparations for the prevention and treatment of gastrointestinal distress,
mucocitis, nausea, vomiting and diarrhea; Pharmaceutical preparations for the prevention and treatment of loss of appetite; Pharmaceutical preparations for the prevention and treatment of weight loss; Pharmaceutical preparations for the treatment and prevention of bone marrow damage; Pharmaceutical preparations for the treatment and prevention of stem cell damage and
reduction of stem cell populations; Pharmaceutical preparations for the
treatment and prevention of blood cell damage, anemia, and low blood
count; Pharmaceutical preparations for the treatment and prevention of dose
limiting side effects of cancer treatments, chemotherapy, radiation therapy,
targeted cancer treatments and immunotherapy treatments; Pharmaceutical preparations for the treatment and prevention of side effects of cancer
treatments, chemotherapy, radiation therapy, targeted cancer treatments
and immunotherapy treatments, namely, reduced fertility; Pharmaceutical preparations for supporting stem cell health and production; Pharmaceutical preparations for supporting stem cell health and production, namely for
stimulating uterine, bone marrow and gastrointestinal track stem cell
production; Pharmaceutical preparations for the treatment of radiation
exposure; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of inflammatory bowel disease,
ulcerative colitis and other inflammatory bowel disorders; Pharmaceutical preparations for the enhancement of chemotherapy; Pharmaceutical preparations for the enhancement of immunotherapy; Fertility enhancement preparations |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, October 22, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Caper Labs, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Francisco, CA 94129 |
Trademark Events
| Event Date | Event Description |
| Wednesday, October 22, 2025 | NEW APPLICATION ENTERED |
| Wednesday, October 22, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, October 22, 2025 | APPLICATION FILING RECEIPT MAILED |
